Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.
Cancers
2021,
13
, 3830
Cancers (Basel)
.
2022 Jul 4;14(13):3268.
doi: 10.3390/cancers14133268.
Authors
Ken Kudura
1
,
Florentia Dimitriou
2
,
Lucas Basler
3
,
Robert Förster
4
,
Daniela Mihic-Probst
5
,
Tim Kutzker
6
,
Reinhard Dummer
2
,
Joanna Mangana
2
,
Irene A Burger
1
7
,
Michael C Kreissl
8
Affiliations
1
Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.
2
Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
3
Center for Proton Therapy, Paul Scherrer Institute, 5232 Villigen, Switzerland.
4
Institute of Radiation Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.
5
Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
6
Faculty of Applied Statistics, Humboldt University Berlin, 10117 Berlin, Germany.
7
Department of Nuclear Medicine, Cantonal Hospital Baden, 5404 Baden, Switzerland.
8
Department of Radiology and Nuclear Medicine, Division of Nuclear Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany.
PMID:
35805065
PMCID:
PMC9265328
DOI:
10.3390/cancers14133268
Abstract
The authors wish to make the following corrections to this paper [...].
Publication types
Published Erratum
Grants and funding
IA USZF27071/Iten-Kohaut-Foundation
CRC_13/Cancer Research Center, Comprehensive Center Zurich, University Hospital Zurich